Cargando…

Focus on a 2019-novel coronavirus (SARS-CoV-2)

A new coronavirus, severe acute respiratory syndrome coronavirus 2, was first discovered in Wuhan, China, in December 2019. As of April 7, 2020, the new coronavirus has spread quickly to 184 countries and aroused the attention of the entire world. No targeted drugs have yet been available for interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ling-Pu, Wang, Meixian, Wang, Yanping, Zhu, Jun, Zhang, Nannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291595/
https://www.ncbi.nlm.nih.gov/pubmed/32524843
http://dx.doi.org/10.2217/fmb-2020-0063
_version_ 1783545937506861056
author Zhang, Ling-Pu
Wang, Meixian
Wang, Yanping
Zhu, Jun
Zhang, Nannan
author_facet Zhang, Ling-Pu
Wang, Meixian
Wang, Yanping
Zhu, Jun
Zhang, Nannan
author_sort Zhang, Ling-Pu
collection PubMed
description A new coronavirus, severe acute respiratory syndrome coronavirus 2, was first discovered in Wuhan, China, in December 2019. As of April 7, 2020, the new coronavirus has spread quickly to 184 countries and aroused the attention of the entire world. No targeted drugs have yet been available for intervention and treatment of this virus. The sharing of academic information is crucial to risk assessment and control activities in outbreak countries. In this review, we summarize the epidemiological, genetic and clinical characteristics of the virus as well as laboratory testing and treatments to understand the nature of the virus. We hope this review will be helpful to prevent viral infections in outbreak countries and regions.
format Online
Article
Text
id pubmed-7291595
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-72915952020-06-12 Focus on a 2019-novel coronavirus (SARS-CoV-2) Zhang, Ling-Pu Wang, Meixian Wang, Yanping Zhu, Jun Zhang, Nannan Future Microbiol Review A new coronavirus, severe acute respiratory syndrome coronavirus 2, was first discovered in Wuhan, China, in December 2019. As of April 7, 2020, the new coronavirus has spread quickly to 184 countries and aroused the attention of the entire world. No targeted drugs have yet been available for intervention and treatment of this virus. The sharing of academic information is crucial to risk assessment and control activities in outbreak countries. In this review, we summarize the epidemiological, genetic and clinical characteristics of the virus as well as laboratory testing and treatments to understand the nature of the virus. We hope this review will be helpful to prevent viral infections in outbreak countries and regions. Future Medicine Ltd 2020-06-11 2020-05 /pmc/articles/PMC7291595/ /pubmed/32524843 http://dx.doi.org/10.2217/fmb-2020-0063 Text en © 2020 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Review
Zhang, Ling-Pu
Wang, Meixian
Wang, Yanping
Zhu, Jun
Zhang, Nannan
Focus on a 2019-novel coronavirus (SARS-CoV-2)
title Focus on a 2019-novel coronavirus (SARS-CoV-2)
title_full Focus on a 2019-novel coronavirus (SARS-CoV-2)
title_fullStr Focus on a 2019-novel coronavirus (SARS-CoV-2)
title_full_unstemmed Focus on a 2019-novel coronavirus (SARS-CoV-2)
title_short Focus on a 2019-novel coronavirus (SARS-CoV-2)
title_sort focus on a 2019-novel coronavirus (sars-cov-2)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291595/
https://www.ncbi.nlm.nih.gov/pubmed/32524843
http://dx.doi.org/10.2217/fmb-2020-0063
work_keys_str_mv AT zhanglingpu focusona2019novelcoronavirussarscov2
AT wangmeixian focusona2019novelcoronavirussarscov2
AT wangyanping focusona2019novelcoronavirussarscov2
AT zhujun focusona2019novelcoronavirussarscov2
AT zhangnannan focusona2019novelcoronavirussarscov2